Jieyu Fang

Dr. Jieyu Fang

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2022 in Frontiers in Pediatrics
Verified
Journal Article
Open access
JLJun Lin
Jun Lin
CWChujun Wu
Chujun Wu
DZDizhou Zhao
Dizhou Zhao
XDXuhang Du
Xuhang Du
WZWangzhi Zhang
Wangzhi Zhang
JFJieyu Fang
Jieyu Fang
Background: Children that need surgery and medical examinations are often uncooperative, and preoperative sedation is necessary. We aimed to assess the safety and efficacy of inhaled nebulized dexmedetomidine in children for sedation that underwent medical examinations or surgery.Methods: We systematically searched PubMed, Web of science, Embase, and Cochrane library, for randomized controlled trials of Intranasal dexmedetomidine using a spray or a mucosal atomization device in children undergoing examination or elective surgery. We included all studies that analyzed the sedation efficiency of intranasal dexmedetomidine in children.Results: Ten studies with 1,233pediatric patients were included. Compared to other sedation treatments, inhaled nebulized dexmedetomidine showed similar sedation satisfaction [risk ratio RR: 1.02; 95% confidence interval (CI): 0.87–1.18; P = 0.83; I2 = 72%]. there was also no statistical difference in the success rate of separation from parents (RR: 0.96; 95% CI: 0.82–1.12; P = 0.58; I2 = 67%), and mask acceptability (RR: 1; 95% CI: 0.83–1.20; P = 0.99; I2 = 35%). But it is worth mentioning that nebulized dexmedetomidine combined with ketamine provided better sedation satisfaction (RR: 0.69; 95% CI: 0.49–0.96; I2 = 49%) and more satisfactory separation from parents (RR: 0.85; 95% CI: 0.74–0.97; I2 = 0%). Moreover, nebulized dexmedetomidine reduced the occurrences of nausea and vomiting (RR: 0.28; 95% CI: 0.15–0.51; P < 0.01; I2 = 10%) and emergence agitation (RR: 0.30; 95% CI: 0.18–0.49; P < 0.01; I2 = 0%). There are no hypotension or arrhythmia reported that required intervention in all articles.Conclusion: Compared to other premedication treatments, inhaled nebulized dexmedetomidine provided equivalent sedation satisfaction for the examination or preoperative sedation of children, but it reduced the occurrences of emergence agitation and postoperative nausea and vomiting.

1 February 2010 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
JFJieyu Fang
Jieyu Fang
JLJian-Wen Lin
Jian-Wen Lin
QLQiang Li
Qiang Li
NJNan Jiang
Nan Jiang
YGYu Gao
Yu Gao

1 February 2021 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
DZDizhou Zhao
Dizhou Zhao
JFJieyu Fang
Jieyu Fang
WXWei Xiong
Wei Xiong
JLJun Lin
Jun Lin
WCWanmei Chen
Wanmei Chen
CWChujun Wu
Chujun Wu
Background: Sugammadex has been a revolutionary reversal of neuromuscular blockade. It is known to be highly efficient. However, a change in the coagulation profile is one of the most dangerous potential complications which is a concern for both surgeon and anesthetist. Bleeding may cause hypovolemic shock, hematoma, and so on. To investigate the effects of sugammadex on coagulation profiles in patients with thyroidectomy, we compared patients that were treated with either sugammadex or neostigmine. Patients and Methods: Eighty patients with thyroid neoplasms undergoing thyroidectomy were randomly allocated to sugammadex group (group S) or neostigmine group (group N). Induction of anesthesia was preformed using propofol, sufentanil, and rocuronium. Group S received sugammadex 2.0mg/kg after trachea intubation, similarly Group N received neostigmine 40 μg/kg, for reversal of rocuronium-induced neuromuscular blockade. The intraoperative coagulation profiles were monitored after the rocuronium injection (T0), 10 minutes after reversal (T1) and 30 minutes after reversal (T2) by testing activated partial thromboplastin time (APTT), prothrombin time (PT), fibrinogen (FIB), thrombin time (TT), and TEG-Haemonetics. Amount of bleeding was recorded during perioperative period. Results: There was no significant difference in the thromboelastogram, APTT, PT, FIB, or TT measurements at each time point in Group N. The reaction time (R time) and kinetics time (K time) of Group S in T1 were significantly longer than the corresponding times at T0 and T2, and the R times were significantly longer than those in Group N at the same time points (P< 0.05). Additionally, in Group S, the APTT was prolonged in T1 and returned to normal in T2. Conclusion: The result showed that sugammadex provided transient efficacy in prolonging the coagulation parameters, while neostigmine did not change the coagulation profile.

23 February 2025 in Health Science Reports
Verified
Journal Article
Open access
WLWanhong Li
Wanhong Li
ZLZhongyuan Lin
Zhongyuan Lin
FLFen Li
Fen Li
KHKecheng Huang
Kecheng Huang
YDYunling Dou
Yunling Dou
JFJieyu Fang
Jieyu Fang
Background and Aims: The use of neuromuscular blocking agents (NMBAs) in tracheal intubation is widely accepted in anesthetic induction, but adverse effects are possible. We performed a systematic review and meta‐analysis to compare influence of use and nonuse of NMBAs on incidence of laryngeal complications and intubating conditions in surgical patients.Methods: We searched PubMed, Web of Science, Embase, and Cochrane Library for randomized controlled trials comparing use of NMBAs with either placebo or no treatment for oral tracheal intubation in adult patients under general anesthesia. Studies were evaluated using a risk‐of‐bias assessment. We conducted random‐effects or fixed‐effects meta‐analyses on extracted data and calculated risk ratio (RR), risk difference (RD), and 95% confidence interval (CI).Results: Nine trials with 1176 participants were included. Incidence of postoperative sore throat or hoarseness did not differ between groups receiving and not receiving NMBAs at 24 h (RR: 1.18; 95% CI: 0.96–1.46; I2 = 45%), 48 h (RR: 0.84; 95% CI: 0.46–1.52; I2 = 42%), or 72 h (RD: −0.00; 95% CI: −0.08 to 0.07; I2 = 59%). Compared with use of NMBAs, induction without NMBAs reduced the occurrence of acceptable intubating conditions (RR: 0.80; 95% CI: 0.67–0.94; I2 = 92%) and with increased risk for poor intubating conditions (RR: 4.77; 95% CI: 3.20–7.10; I2 = 0%). The pharmacological interventions for hemodynamic changes after intubation did not differ significantly between the NMBAs and non‐NMBAs groups (RR: 1.02; 95% CI: 0.53–1.95; I2 = 78%).Conclusion: Endotracheal intubation without NMBAs does not increase the incidence of postoperative hoarseness or sore throat in adult surgical patients, which may be considered as a safe and effective technique of anesthesia induction. Although NMBAs use was associated with acceptable intubating conditions and reduced risk for poor intubation conditions.Trial Registration: PROSPERO CRD42021284813

22 August 2025 in JMIR Medical Informatics
Verified
Journal Article
Open access
KHKecheng Huang
Kecheng Huang
CWChujun Wu
Chujun Wu
RPRongpeng Pi
Rongpeng Pi
JFJieyu Fang
Jieyu Fang
This viewpoint article explores the transformative role of artificial intelligence (AI) in predicting perioperative hypoxemia through the integration of deep learning with multimodal clinical data, including lung imaging, pulmonary function tests, and arterial blood gas (ABG) analysis. Perioperative hypoxemia, defined as arterial oxygen partial pressure <60 mmHg or oxygen saturation <90%, poses significant risks of delayed recovery and organ dysfunction. Traditional diagnostic methods such as radiological imaging and ABG analysis often lack integrated predictive accuracy. AI frameworks, particularly convolutional neural networks and hybrid models like TD-CNNLSTM-LungNet, demonstrate exceptional performance in detecting pulmonary inflammation and stratifying hypoxemia risk, achieving up to 96.57% accuracy in pneumonia subtype differentiation and an area under the curve of 0.96 for postoperative hypoxemia prediction. Multimodal AI systems, such as DeepLung-Predict, unify computed tomography scans, pulmonary function tests, and ABG parameters to enhance predictive precision, surpassing conventional methods by 22%. However, challenges persist, including dataset heterogeneity, model interpretability, and clinical workflow integration. Future directions emphasize multicenter validation, explainable AI frameworks, and pragmatic trials to ensure equitable and reliable deployment. This AI-driven approach not only optimizes resource allocation but also mitigates financial burdens on health care systems by enabling early interventions and reducing intensive care unit admission risks.

1 January 2025 in International Medical Case Reports Journal
Verified
Journal Article
Open access
PDF file
YLYucheng Lai
Yucheng Lai
WLWanhong Li
Wanhong Li
DZDizhou Zhao
Dizhou Zhao
XLXiaoyang Liang
Xiaoyang Liang
JFJieyu Fang
Jieyu Fang
Background: Post-dural puncture headache (PDPH) is a common complication of obstetric anesthesia. There are still no convenient and effective methods to control the PDPH. Case Presentation: Three cases of parturients with accidental dural puncture who suffered post-dural puncture headache (PDPH) after labor analgesia or cesarean section. They were treated with epidural hydroxyethyl starch (HES) through an epidural catheter and achieved well therapeutic effect. Conclusion: Treatment of PDPH by epidural HES is a promising method that may benefit the parturient and doctor.